Market News

FPIs get tax relief on gilts, ease of Investment

In a strategic step to lure foreign investment, India has eliminated taxes on capital gains and interest for overseas investors in its government bonds. This change, set to take effect on April 1, is part of an ordinance aimed at enhancing the appeal of Indian sovereign bonds and fortifying the strength of the rupee.

Paras Healthcare plans ₹1,800 crore IPO, files draft papers with Sebi

Paras Healthcare Ltd, which operates hospitals under the 'Paras Health' brand, has filed preliminary papers with capital markets regulator Sebi to raise up to Rs 1,800 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an Offer-For-Sale (OFS) of equity shares worth up to Rs 1,300 crore by the selling shareholder, according to the draft red herring prospectus (DRHP) filed on Thursday. Those selling shares include promoter Dharminder Kumar Nagar and other investors. The Gurugram-based company intends to utilise the proceeds from the fresh issue towards prepayment or repayment of certain outstanding borrowings, investment in its wholly-owned subsidiary PMHPL for its debt payment, and for general corporate purposes. Paras Healthcare is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate capacity of

RBI announces measures to attract foreign capital

The Reserve Bank of India (RBI) has announced few measures in order to attract capital flow. Firstly, for government securities under the Fully Accessible Route (FAR), the central bank is expanding the universe of specified securities by including all new issuances of 15-, 30- and 40-year tenor G-secs. In addition, limits pertaining to short-term investment, concentration and individual securities on FPI investment under the General Route are being removed. These measures along with the tax benefits provided by the government this morning should help attract foreign capital for government borrowing. Second, the limits for investment by NRIs and OCIs in equity instruments traded on the stock market without SEBI registration are being increased. Further, the same facility is being extended to all individual Persons Resident Outside India (PROIs) at par with NRIs and OCIs. Third, a facility of concessional forex swap will be provided till 30th September 2026 to incentivize ECBs by PSUs.

Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in Focus - Dalal Street Investment Journal

Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in FocusDalal Street Investment Journal

Shilpa Biocare to acquire 30.4% stake in Barcelona-based Gate2Brain

Shilpa Medicare announced that its wholly owned subsidiary, Shilpa Biocare intends to make a strategic equity partnership of 30.4% in Gate2Brain. The investment of Euro 7 million includes cash infusion of Euro 0.5 million, equity for services Euro 5.5 million and Euro 1 million for development of project.

Shilpa Medicare to acquire 30.4% stake in Spain's Gate2Brain with €7 million investment

The global glioblastoma treatment market is estimated at approximately $3 billion in 2025 and is projected to exceed $6 billion by 2035. The pediatric brain tumour market is estimated at around $1.5 billion, while the market for DIPG therapies is expected to reach nearly $1.2 billion by 2035.

Hero MotoCorp Share Price Live Updates: Hero MotoCorp's beta indicates potential investment risk

India and US have finalised most elements of first phase of Bilateral Trade Agreement, says Piyush Goyal

Commerce and Industry Minister Piyush Goyal has said India and the US have finalised most elements of the first phase of the bilateral trade agreement. The two sides are proposed to finalise the details of the interim agreement and take forward the negotiations under the broader BTA on multiple areas, such as market access, non-tariff measures, customs and trade facilitation and investment promotion. India and the US issued a joint statement on February 7, finalising the framework of the first phase of the BTA, also referred to as an interim trade agreement. Both sides will now have to finalise the legal text for the deal. The framework reaffirmed the countries commitment to the broader India-US BTA negotiations. The US was the second-largest trading partner of India in 2025-26.

Stocks to buy for long term: Tata Steel, EIL among 5 stocks ICICI Securities' Pankaj Pandey suggests for up to 36% gains

Stocks to buy for long term: ICICI Securities' Pankaj Pandey recommends five quality stocks poised for long-term gains. From Artemis Medicare, EIL to Tata Steel, discover the compelling reasons behind these picks and how they can bolster your investment portfolio in the coming years.

Govt health spending triples to Rs 3.85 lakh crore in 2022-23: National Health Accounts

Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public investment has led to a substantial drop in household out-of-pocket expenses for treatment. The share of government health spending in GDP has also risen. This indicates a positive shift towards more affordable and accessible healthcare for all citizens.

True North buys 25% stake in pharma co Embio

Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.

Schroders Capital plans to build on $1 bn India investment as scope for early investor exits grows beyond IPOs

The company is scouting for opportunities in sectors including consumer, healthcare, technology and artificial intelligence.